Thrombin-JMI 5,000 units vials

Ended Awarded Last action

Contract number
SPE2DR26FGHX3
Awardee
Awarding agency
Obligated
$2,696

Award facts

Contract value 100% obligated
$2,695.78 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $2,695.78 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 22, 2026, for 5,000 units of Thrombin-JMI vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. The order carries a firm fixed price and an ultimate completion date of April 23, 2026. Place of performance is Park Ridge, Illinois.

Quick answers

Who was awarded contract SPE2DR26FGHX3?

SPE2DR26FGHX3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 22, 2026.

How much is contract SPE2DR26FGHX3 worth?

The government has obligated $2,696 on SPE2DR26FGHX3.

Is contract SPE2DR26FGHX3 an order under another contract?

Yes. SPE2DR26FGHX3 is a delivery order under SPE2DR25D9381, an indefinite delivery contract.

Was contract SPE2DR26FGHX3 competed?

The extent of competition for SPE2DR26FGHX3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award